Clinical Trials Browser

Phase 1 × Triple Negative Breast Neoplasms × Disulfides × Clear all

NCT03544125 2020-11-20

Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer

Phase 1 Completed

Triple Negative Breast Neoplasms